Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × Calcium Dobesilate × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Burkitt Lymphoma 5 Recurrence 4 Leukemia, Biphenotypic, Acute 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Fatigue 1 Down Syndrome 1 Cytokine Release Syndrome 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

venetoclax 61 Azacitidine 51 Cytarabine 33 Specimen Handling 28 Biopsy 21 fludarabine 19 Daunorubicin 18 Injections 17 Decitabine 16 fludarabine phosphate 13 Cyclophosphamide 13 Whole-Body Irradiation 12 CPX-351 12 Idarubicin 11 Melphalan 10 Stem Cell Transplantation 9 Busulfan 9 gilteritinib 8 decitabine and cedazuridine drug combination 8 Mycophenolic Acid 8 Granulocyte Colony-Stimulating Factor 8 Magnetic Resonance Spectroscopy 7 Liposomes 7 Filgrastim 7 ivosidenib 6 enasidenib 6 Gemtuzumab 6 revumenib 5 olutasidenib 5 Mesna 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡